Pathologic splenic rupture as the presentation of mantle cell lymphoma

A H Strickland1, K A Marsden, J McArdle

  • 1Clinical Haematology & Medical Oncology Unit; Royal Hobart Hospital, Hobart, Australia.

Insights

Pathologic splenic rupture is a rare complication of non-Hodgkin's lymphoma (NHL). This case highlights mantle cell lymphoma (MCL) as a potentially vulnerable subtype, presenting with splenic rupture and aggressive disease progression.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Pathologic splenic rupture is a rare but serious complication of non-Hodgkin's lymphoma (NHL).
  • Initial presentation of NHL with splenic rupture is exceptionally uncommon.
  • Mantle cell lymphoma (MCL) is an uncommon subtype of NHL.

Observation:

  • A case of an 80-year-old male with mantle cell lymphoma (MCL) presenting with spontaneous splenic rupture is described.
  • Three prior reported cases of pathologic splenic rupture in NHL also involved MCL.
  • The patient underwent splenectomy, after which his MCL exhibited high-grade behavior.

Findings:

  • This case represents a rare initial presentation of MCL with pathologic splenic rupture.
  • MCL may represent a subtype of NHL with increased vulnerability to splenic rupture.
  • The patient's MCL demonstrated aggressive behavior post-splenectomy, leading to a poor prognosis despite initial treatment response.

Implications:

  • This case underscores the importance of considering splenic rupture in the differential diagnosis of NHL presentations.
  • It suggests a potential predisposition for splenic rupture in patients with MCL.
  • The findings highlight the aggressive nature MCL can exhibit, emphasizing the need for vigilant monitoring and timely therapeutic interventions.

Related Concept Videos